Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Medtronic
Covington
Baxter
Boehringer Ingelheim
Citi
Moodys
Accenture
US Army

Generated: January 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Faldaprevir

« Back to Dashboard

US Patents for Faldaprevir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Faldaprevir ➤ Try a Free Trial Hepatitis C inhibitor compounds Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) ➤ Try a Free Trial
Faldaprevir ➤ Try a Free Trial Hepatitis C inhibitor compounds Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) ➤ Try a Free Trial
Faldaprevir ➤ Try a Free Trial Crystalline forms of a potent HCV inhibitor Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) ➤ Try a Free Trial
Faldaprevir ➤ Try a Free Trial Crystalline forms of a potent HCV inhibitor Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) ➤ Try a Free Trial
Faldaprevir ➤ Try a Free Trial Methods for treating HCV AbbVie Inc. (North Chicago, IL) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Faldaprevir

Drugname Country Document Number Estimated Expiration Related US Patent
Faldaprevir Austria 378334 2023-05-21 ➤ Try a Free Trial
Faldaprevir Australia 2004240704 2023-05-21 ➤ Try a Free Trial
Faldaprevir Brazil PI0410456 2023-05-21 ➤ Try a Free Trial
Faldaprevir Canada 2522577 2023-05-21 ➤ Try a Free Trial
Faldaprevir Chile 2004001161 2023-05-21 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Accenture
Cantor Fitzgerald
Merck
Chinese Patent Office
QuintilesIMS
Queensland Health
Dow
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.